2. 筋萎縮性側索硬化症 Amyotrophic lateral sclerosis Clinical trials / Disease details

臨床試験数 : 624 / 薬物数 : 611 - (DrugBank : 160) / 標的遺伝子数 : 172 - 標的パスウェイ数 : 225

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00919555 (ClinicalTrials.gov)	June 2008	8/6/2009	Combination Therapy in Amyotrophic Lateral Sclerosis (ALS)	Phase IIA Trial: Tretinoin and Pioglitazone HCL Combination Therapy in Amyotrophic Lateral Sclerosis	Amyotrophic Lateral Sclerosis	Drug: Pioglitazone and Tretinoin;Drug: Tretinoin and Pioglitazone HCL;Drug: Placebo	Phoenix Neurological Associates, LTD	NULL	Completed	18 Years	85 Years	Both	28	Phase 1/Phase 2	United States
2	NCT00690118 (ClinicalTrials.gov)	May 2008	2/6/2008	Study of Pioglitazone in Patients With Amyotrophic Lateral Sclerosis	Efficacy, Safety and Tolerability Study of 45 mg Pioglitazonein Patients With Amyotrophic Lateral Sc ...	Amyotrophic Lateral Sclerosis	Drug: pioglitazone;Drug: placebo	University of Ulm	NULL	Terminated	18 Years	N/A	Both	219	Phase 2	Germany;Italy
3	EUCTR2006-005410-13-DE (EUCTR)	22/04/2008	21/01/2008	EFFICACY, SAFETY AND TOLERABILITY STUDY OF 45 mg PIOGLITAZONEIN PATIENTS WITH AMYOTROPHIC LATERAL SC ...	EFFICACY, SAFETY AND TOLERABILITY STUDY OF 45 mg PIOGLITAZONEIN PATIENTS WITH AMYOTROPHIC LATERAL SC ...	Male or female adult patients with amyotrophic lateral sclerosis (ALS) accoring to the El Escorial C ...	Trade Name: Actos 15 mg INN or Proposed INN: Pioglitazone Trade Name: Actos 30 mg INN or Proposed INN: ...	University Hospital of Ulm	NULL	Not Recruiting			Female: yes Male: yes			Germany

First Previous1Next Last